StephenRossMD
Psychiatry • New York, NYAddiction
Associate Professor, Psychiatry, New York University School of Medicine
Dr. Ross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 E 35th St
Rm 1M
New York, NY 10016Phone+1 212-562-4097Fax+1 212-263-8285
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1996 - 2000
David Geffen School of Medicine at UCLAClass of 1996
Certifications & Licensure
NY State Medical License 1997 - 2026- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Psilocybin Cancer Anxiety Study Start of enrollment: 2009 Feb 01
- Aprepitant Effects in Intravenous Heroin Dependence Start of enrollment: 2012 Jan 01
- A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 199 citationsPercentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Cli...Michael P Bogenschutz, Stephen Ross, Snehal Bhatt, Tara Baron, Alyssa A Forcehimes
JAMA Psychiatry. 2022-10-01 - 8 citationsCo-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.Richard J Zeifman, Hannes Kettner, Broc A Pagni, Austin Mallard, Daniel E Roberts
Scientific Reports. 2023-08-22 - 11 citationsDiagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain.Deborah S Hasin, Dvora Shmulewitz, Malka Stohl, Eliana Greenstein, Efrat Aharonovich
The American Journal of Psychiatry. 2022-10-01
Press Mentions
How Psychedelic Drugs Can Aid Patients at the End of LifeOctober 4th, 2024- Psilocybin Therapy for PTSD and Depression – Cannabis Science and TechnologyJune 10th, 2022
- Psychiatrists Are Set to Begin Trialling MDMA on Ex-Servicemen Suffering with Post-Traumatic StressJune 6th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
